rs Selective M3 muscarinic antagonist CS2=322aa 3 EFTA00810554 Experienced in clinical practice, drug development and commercialization vett Mitchell Steiner, MD CHAIRMAN, PRESIDENT & CEO CEO & President Aspen Pork Pharmaceuticals. President of Urology at OPKO Health. Inc.: CEO & Founder Cir. Inc.: